BMJ NO 7023 Volume 312 Saturday 13 January 1996

  • Press releases
  • This Week in BMJ
  • Editor's Choice: Third generation contraceptive pills: the continuing saga

  • Editorials

  • 67 Raw milk: cheeses and salmonella Anita Rampling
  • 68 Third generation oral contraception and venous thromboembolism Klim McPherson
  • 69 Men's health Sian Griffiths
  • 70 Contestability: a middle path for health care Chris Ham
  • 71 Evidence based medicine: what it is and what it isn't David L Sackett, William
  • M C Rosenberg, J A Muir Gray, R Brian Haynes, W Scott Richardson

  • News

    73 Doctors' hunger strike in Bombay * Australia confidentiality row * Pharmacy staff criticised * German health insurance deficit * Personality and genetics * Older women and breast screening * India and prescribing * Dutch euthanasia prosecutions * Britain puts asylum children at risk * French cancer charity investigated * German heart valve scandal * NHS reforms need reform * Doctors as Delilahs


    Papers

  • 79 Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers K S Joseph, Lucie Blais, Pierre Ernst, Samy Suissa
  • 82 Commentaries: Teifion Davies; Mark L Levy
  • 83 Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study Walter O Spitzer, Michael A Lewis, Lothar A J Heinemann, Margaret Thorogood, Kenneth D MacRae on behalf of Transnational Research Group on Oral Contraceptives and the Health of Young Women
  • 88 Third generation oral contraceptives and risk of myocardial infarction: an international case-control study Michael A Lewis, Walter O Spitzer, Lothar A J Heinemann, Kenneth D MacRae, Rudolf Bruppacher, Margaret Thorogood on behalf of Transnational Research Group on Oral Contraceptives and the Health of Young Women
  • 91 Large outbreak of Salmonella enterica serotype paratyphi B infection caused by a goats' milk cheese, France, 1993: a case finding and epidemiological study Jean-Claude Desenclos, Philippe Bouvet, Elisabeth Benz-Lemoine, Francine Grimont, Helene Desqueyroux, Isabelle Rebiere, Patrick A Grimont
  • 94 Ethnic differences in the outcome of serum screening for Down's syndrome Lucy Gilbert, Jon Nicholl, Susie Alex, Ian Smethurst, Anthony Mander, Anthony Andrews, Janet Patrick
  • 95 Genetics versus environment in inflammatory bowel disease: results of a British twin study Nick P Thompson, Richard Driscoll, Roy E Pounder, Andrew J Wakefield
  • 96 Correction: Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons Campbell and others

  • General Practice

  • 97 Vocational training for general practice in inner London. Is there a dearth? And if so what's to be done? Tess Harris, Trevor Silver, Elizabeth Rink, Sean Hilton
  • 101 Measles and rubella misdiagnosed in infants as exanthem subitum (roseola infantum) Dereck R Tait, Katherine N Ward, David W G Brown, Elizabeth Miller

  • Education & Debate

  • 103 Fortnightly Review: Intermittent catheterisation: simple, safe, and effective but underused Gillian M Hunt, Pippa Oakeshott, Robert H Whitaker ;
  • 107 Lesson of the Week: Insidiously evolving, occult drug interaction involving warfarin and amiodarone B Cheung, F M Lam, C R Kumana
  • 109 Clinical system security: interim guidelines Ross Anderson
  • 112 ABC of Atrial Fibrillation: Cardioversion of atrial flbrillation Gregory Y H Lip, Robert D S Watson, Shyam P Singh
  • 115 Job sharing at a children's hospital: evaluation by medical staff Jane P Valentine, Cherry J Martin

  • Obituaries

    C M Fletcher, T C Chalmers, A S Anderson, H Climie, E A F Dickie, C J Frederick, G B Hollings, D F McLauchlan,M L Soni


    Letters

  • 119 Impact of specialised paediatric retrieval teams Q Mok and others; A Morrison and C Runcie; A Kelleher and L Murdoch; A Raffles; R M Cooper; S H Cray; A Sharples and others; J Britto and others
  • 121 Guidelines for prescribing combined oral contraceptives A M Mills and others
  • 122 Safety of complementary medicines should be monitored HM Saw
  • 122 Monitoring children's growth P C Hindmarsh; J A Hulse and S Schilg
  • 122 Extra costs for disabled people R Hull and A O Frank
  • 123 Topical treatments for head lice R Dixon and others; G M Laekeman; R H Vander Stichele and others
  • 124 Training of overseas qualified doctors in Britain N Harrison
  • 124 Urban hypothermia R Morgan and others; D S G Sloan
  • 124 Prioritised ambulance call out may be necessary D J Hall
  • 125 Misleading meta-analysis R Persaud; S Evans
  • 125 Incidence of HIV infection decreases because of nature of epidemics S Brody
  • 125 People's cultural beliefs should be respected P Q Shaw

  • Medicopolitical Digest

    Summative assessment * Juniors' contracts * Waiting lists * Violence against doctors * Assessing mental capacity * Transplanting animal organs to humans * Changes to PLAB test


    Soundings

    Quangoholics anonymous James Owen Drife; Evidence based politics Tony Smith


    Personal View

    Gifts Huw Morgan; Time to audit audit David Sellu


    Medicine and the Media

    Trying experts Philip Joseph


    Medicine and Books

  • 130 Ann Ashworth: Nutrition in Child Health (Ed D P Davies)
  • 130 Veena Soni Raleigh: Health Policies in Developing Countries (Ed Anne Mills, Anthony B Zwi)
  • 131 Sten Iwarson: The War Against Hepatitis B (William Muraskin)
  • 131 Ian Capperauld: Guide to Organizing an International Scientific Conference (Gideon Rivlin)

  • Minerva


    BMJ

    Editor's Choice

    Third generation contraceptive pills: the continuing saga

    This week we add yet another twist to the story of the risks associated with third generation contraceptive pills, and maybe it's time for the sociologists to begin work on analysing the episode.

    The story began last October when the British Committee on Safety of Medicines (CSM) announced on the basis of unpublished data that the risk of thromboembolism in women using third generation pills was about twice that in women using longer established pills. Doctors were upset that they first heard about the risks through the mass media. Manufacturers thought that the CSM had acted prematurely. Some observers muttered about the government wanting to reduce costs by discouraging people from using the more expensive pills; others speculated that British politicians were anxious to prove their independence from European authorities; while a few were gratified that the drug companies that had promoted their new drugs on dubious grounds had got their comeuppance. Meanwhile, older women - brought up on pill scares - generally seemed to react sensibly, but some younger women may have stopped taking any pill.

    The next development came just before Christmas, when the Lancet published data from three studies confirming the risk. By now the media were beginning to tire of the story, and the relatively small coverage was devoted to ideas on better ways to let doctors and others know about such risks. Surely a way could be found to publish peer reviewed results and make a public announcement at the same time.

    Today we publish one of the studies used by the CSM, and it confirms the higher risk of thromboembolic disease (p 83). But a second paper from the same study suggests that the risk of myocardial infarction might be lower in women taking the third generation pills than in those taking longer established pills (p 88). These data will remain forever preliminary because the studies were interrupted by the "scare," and editorialist Klim McPherson thinks that such data "cannot provide a reliable basis for policy decisions on safe contraception" (p 68). Both Professor McPherson and the Faculty of Family Planning and Reproductive Health Care (p 121) provide straightforward advice on prescribing the pill.

    Our obituary columns include accounts of two remarkable men - Charles Fletcher and Tom Chalmers - who would no doubt have been fascinated by the messy saga of the pill. Fletcher is perhaps best known as the secretary to the Royal College of Physicians working party that produced the college's first report on smoking and as the first British doctor to excel on television (p 117). He believed that doctors failed to explain things adequately to patients, and he was much criticised - including by the BMJ - for his work on television. Now doctors and hospitals are fighting to get on television. Chalmers, an American epidemiologist, was another who challenged conventional thinking, and he produced the commandment "randomise the first patient" (p 118). He extended his commandment to saving money by blinded wine tasting.


    Back to BMJ Home Page